These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36746036)

  • 1. A review on the role of ADAMTS9-AS2 in different disorders.
    Ghafouri-Fard S; Askari A; Hussen BM; Baniahmad A; Taheri M; Mokhtari M
    Pathol Res Pract; 2023 Mar; 243():154346. PubMed ID: 36746036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
    Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
    Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer.
    Chen Z; Tang W; Ye W; Song L; Chen Z
    Cell Cycle; 2022 Aug; 21(16):1710-1725. PubMed ID: 35503407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS9-AS2 Promotes Angiogenesis of Brain Microvascular Endothelial Cells Through Regulating miR-185-5p/IGFBP-2 Axis in Ischemic Stroke.
    Feng N; Wang Z; Wu Y; Zheng H; Jiang X; Wang Z; Qu F; Zhang Z
    Mol Neurobiol; 2022 Apr; 59(4):2593-2604. PubMed ID: 35098480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
    Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
    Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
    Wang A; Jin C; Li H; Qin Q; Li L
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
    Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
    Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling.
    Xie S; Yu X; Li Y; Ma H; Fan S; Chen W; Pan G; Wang W; Zhang H; Li J; Lin Z
    Mol Ther; 2018 Dec; 26(12):2766-2778. PubMed ID: 30217729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p.
    Guo Q; Ni P; Dai Y; Hu J; Yao Y
    J Interferon Cytokine Res; 2021 Feb; 41(2):60-71. PubMed ID: 33621133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
    Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
    IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis.
    Xu W; Wang B; Cai Y; Chen J; Lv X; Guo C; Yuan C
    Curr Pharm Des; 2021; 27(23):2722-2727. PubMed ID: 33823762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p.
    Shi YF; Lu H; Wang HB
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M6A Promotes Colorectal Cancer Progression via Regulating the miR-27a-3p/BTG2 Pathway.
    Liu W; Zhang Z; Luo X; Qian K; Huang B; Deng J; Yang C
    J Oncol; 2023; 2023():7097909. PubMed ID: 36816363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Shen FF; Zhang F; Yang HJ; Li JK; Su JF; Yu PT; Zhou FY; Che GW
    Biomark Med; 2020 Oct; 14(15):1415-1426. PubMed ID: 32892630
    [No Abstract]   [Full Text] [Related]  

  • 16. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis.
    Xin J; Zhao YH; Zhang XY; Tian LQ
    Hum Cell; 2020 Oct; 33(4):1273-1280. PubMed ID: 32779154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA ADAMTS9-AS2 regulates periodontal ligament cell migration under mechanical compression via ADAMTS9/fibronectin.
    Yu Q; Guo K; Yang Y; Liu H; Huang Y; Li W
    J Periodontal Res; 2024 Feb; 59(1):174-186. PubMed ID: 37957805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
    Xiao S; Song B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
    Zhang X; Niu W; Mu M; Hu S; Niu C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.